Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct;87(10):4040-4041.
doi: 10.1111/bcp.14820. Epub 2021 Mar 24.

Zolpidem: A masked hero. A reply to ZORRO study

Fabio Lugoboni  1 , Rebecca Casari  1 , Francesca Fusina  2   3 , Lorenzo Zamboni  1   4
Affiliations
Comment

Zolpidem: A masked hero. A reply to ZORRO study

Fabio Lugoboni et al. Br J Clin Pharmacol. 2021 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no competing interests to declare.

Comment on

References

    1. Istvan M, Caillet P, Rousselet M, et al. Change in the regulatory framework for zolpidem: what is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study. Br J Clin Pharmacol. 2021;1–10. Epub ahead of print. 10.1111/bcp.14753 - DOI - PubMed
    1. Faccini M, Tamburin S, Casari R, Morbioli L, Lugoboni F. High‐dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde. Intern Emerg Med. 2019;14(8):1271–1278. 10.1007/s11739-019-02101-8 - DOI - PubMed
    1. Rousselet M, Feuillet F, Gerardin M, Jolliet P, Hardouin JB, Victorri‐Vigneau C. The French addictovigilance network clinical assessment: Z‐drugs, true false twins. Expert Opin Drug Saf. 2017;16(9):1063–1069. 10.1080/14740338.2017.1346084 - DOI - PubMed
    1. Costa E, Sterzi E, Tedeschi F, Casari R, Marini P, Lugoboni F. Can oral formulation increase the risk of lormetazepam abuse? Intern Emerg Med. 2020. Epub ahead of print. 10.1007/s11739-020-02538-2 - DOI - PubMed
    1. Lugoboni F, Bertoldi A, Casari R, Mantovani E, Morbioli L, Tamburin S. Adult attention‐deficit/hyperactivity disorder and quality of life in high‐dose benzodiazepine and related Z‐drug users. Eur Addict Res. 2020;26(Suppl. 4‐5):274–282. 10.1159/000507852 - DOI - PubMed

LinkOut - more resources